Related Experiment Video
Updated: Jan 17, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Harnessing AI for precision medicine and its applications in genomics, systems pharmacology, and drug discovery
Jane Dagher1, Moussa Nassar1, Wissam H Faour1
1Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Byblos, Lebanon.
Abstract:
Artificial intelligence and machine learning are revolutionizing pharmaceutical research by enabling the rapid analysis of complex datasets and automating critical tasks throughout the drug-development process. In this review, we surveyed how artificial intelligence accelerated target identification, guided lead-compound design and enhanced safety and efficacy profiling through predictive ADMET modeling and PK/PD simulations. We also explored downstream applications, including modelling complex biological interactions and leveraging real-world clinical data, while emphasizing the essential requirements for model validation and interpretability. While still in its early stages, AI in pharmacology is poised for rapid progress, driving future innovations.
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Drug Discovery: Overview
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Genomics
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
